132 related articles for article (PubMed ID: 7846018)
1. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages.
Matsumoto S; Harada H; Tanaka J; Ochi K; Seno T; Tsurumi T; Kunichika K
Pancreas; 1994 Nov; 9(6):741-7. PubMed ID: 7846018
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of pancreatic cancer by cytology and measurement of oncogene and tumor markers in pure pancreatic juice aspirated by endoscopy.
Nakaizumi A; Uehara H; Takenaka A; Uedo N; Sakai N; Yano H; Ohigashi H; Ishikawa O; Ishiguro S; Sugano K; Tatsuta M
Hepatogastroenterology; 1999; 46(25):31-7. PubMed ID: 10228761
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of supernatant of pancreatic juice for genetic analysis of K-ras in diagnosis of pancreatic carcinoma.
Ha A; Watanabe H; Yamaguchi Y; Ohtsubo K; Wang Y; Motoo Y; Okai T; Wakabayahi T; Sawabu N
Pancreas; 2001 Nov; 23(4):356-63. PubMed ID: 11668203
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric tumor marker (CA 19-9, CEA, AFP, POA) analyses of pancreatic juices and sera in pancreatic diseases.
Schmiegel WH; Eberl W; Kreiker C; Kalthoff H; Bützow GH; Jessen K; Klapdor R; Soehendra N; Wargenau M; Classen M
Hepatogastroenterology; 1985 Jun; 32(3):141-5. PubMed ID: 2410346
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of pancreatic oncofetal antigen (POA) in the diagnosis of pancreatic cancer].
Nishida K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):601-8. PubMed ID: 6349542
[TBL] [Abstract][Full Text] [Related]
6. Significance of carcinoembryonic antigen levels and cytology of pure pancreatic juice in diagnosis of pancreatic cancer.
Tatsuta M; Yamamura H; Yamamoto R; Okano Y; Morii T; Okuda S; Tamura H
Cancer; 1983 Nov; 52(10):1880-5. PubMed ID: 6627206
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice.
Naito Y; Okabe Y; Nagayama M; Nishinakagawa T; Taira T; Kawahara A; Hattori S; Machida K; Ishida Y; Kaji R; Mikagi K; Kinoshita H; Yasumoto M; Akiba J; Kage M; Nakashima M; Ohshima K; Yano H
Med Mol Morphol; 2011 Jun; 44(2):86-92. PubMed ID: 21717311
[TBL] [Abstract][Full Text] [Related]
8. Cytologic studies for the diagnosis of pancreatic cancer.
Goodale RL; Gajl-Peczalska K; Dressel T; Samuelson J
Cancer; 1981 Mar; 47(6 Suppl):1652-5. PubMed ID: 7272915
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of the value of imaging, serum markers and their combination in the diagnosis of pancreatic carcinoma in symptomatic patients.
Pasanen PA; Eskelinen M; Partanen K; Pikkarainen P; Penttilä I; Alhava E
Anticancer Res; 1992; 12(6B):2309-14. PubMed ID: 1295478
[TBL] [Abstract][Full Text] [Related]
10. [Accuracy of imaging techniques and tumor markers in the diagnosis of pancreatic cancer].
Clavé P; Boadas J; González-Carro P; Mora J; Pérez C; Martínez A; Roca M; Lluís F; Farré A
Gastroenterol Hepatol; 1999; 22(7):335-41. PubMed ID: 10535205
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.
Uno K; Azuma T; Nakajima M; Yasuda K; Hayakumo T; Mukai H; Sakai T; Kawai K
J Gastroenterol Hepatol; 2000 Nov; 15(11):1333-8. PubMed ID: 11129230
[TBL] [Abstract][Full Text] [Related]
12. [Functional tests during endoscopic retrograde cholangio-pancreatography (ERCP) (author's transl)].
Fölsch UR
Z Gastroenterol; 1978 Mar; 16(3):149-55. PubMed ID: 636508
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of tumor markers associated with pancreatic cancer].
Watanabe H; Kawakami H; Yamakawa O; Satomura Y; Ohta H; Motoo Y; Okai T; Sawabu N
Rinsho Byori; 1994 Feb; 42(2):127-38. PubMed ID: 7908065
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography in patients with chronic abdominal pain of suspected pancreatic origin.
Wiersema MJ; Hawes RH; Lehman GA; Kochman ML; Sherman S; Kopecky KK
Endoscopy; 1993 Nov; 25(9):555-64. PubMed ID: 8119204
[TBL] [Abstract][Full Text] [Related]
15. Significance of K-ras mutation and CEA level in pancreatic juice in the diagnosis of pancreatic cancer.
Futakawa N; Kimura W; Yamagata S; Zhao B; Ilsoo H; Inoue T; Sata N; Kawaguchi Y; Kubota Y; Muto T
J Hepatobiliary Pancreat Surg; 2000; 7(1):63-71. PubMed ID: 10982594
[TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay.
Watanabe H; Yamaguchi Y; Ha A; Hu YX; Motoo Y; Okai T; Yoshimura T; Sawabu N
Pancreas; 1998 Nov; 17(4):341-7. PubMed ID: 9821175
[TBL] [Abstract][Full Text] [Related]
17. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of secreted apoptosis-related protein 2 (SARP2) in pure pancreatic juice in diagnosis of pancreatic neoplasms.
Watanabe H; Okada G; Ohtsubo K; Yao F; Jiang PH; Mouri H; Wakabayashi T; Sawabu N
Pancreas; 2006 May; 32(4):382-9. PubMed ID: 16670620
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
20. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
